SHERIDAN, WYOMING – May 8, 2025 – B. Braun Group has demonstrated resilience and strategic growth amidst challenging global conditions, reporting a 4.4% increase in sales for the 2024 fiscal year. The company’s focus on innovation, operational efficiency, and modern technology investments has contributed to a solid financial performance, reaffirming its commitment to advancing healthcare solutions worldwide.
Robust Financial Growth and Increased Efficiency
In a year marked by rising costs and market volatility, B. Braun’s fiscal year 2024 results showcase the company’s ability to drive growth and improve profitability. The company’s sales surged to 9.1 billion euros, up from 8.8 billion euros the previous year. At constant exchange rates, this represents a notable 6.8% increase, aligning with B. Braun’s long-term growth target of 5-7%.
Key highlights from the 2024 fiscal year include:
- Profit Before Taxes: Up by 31.1%, reaching 270 million euros (previous year: 206 million euros).
- EBITDA: Increased to 1.1 billion euros, a 7.9% rise compared to the prior year.
- Gross Margin: Improved by 1.3 percentage points to 39.2%, reflecting enhanced production efficiencies and growth in profitable segments.
B. Braun’s ability to improve operational efficiency was crucial in offsetting higher costs, such as energy, raw materials, and personnel expenses. This strategic focus has allowed the company to remain financially stable and continue investing in key initiatives.
Strategic Investments and Technological Advancements
In 2024, B. Braun invested significantly in research and development, committing 1.3 billion euros to new technologies, production capacity expansion, and process optimization. This investment represents 5.8% of the company’s total sales revenue, with plans to increase this to over 6% in the coming years.
“We are pleased with development in the 2024 fiscal year,” said Anna Maria Braun, CEO of B. Braun SE. “The sales growth is a clear indicator that our products and solutions are convincing. Thanks to our clear focus and discipline, we have achieved a good improvement in result. This is a strong performance by all employees, enabling us to continue investing in modern technologies for better healthcare.”
Innovations Shaping the Future of Healthcare
B. Braun continues to innovate in the medical technology sector, focusing on integrating products, software, and services to provide smart solutions that enhance patient care. The Spaceplus infusion pump system and OnlineSuiteplus are prime examples of B. Braun’s commitment to digitalization and improving healthcare workflows through modern connectivity and data management.
Additional innovations in 2024 include:
- Intensive Care Solutions: B. Braun partnered with other medical device manufacturers to develop a solution for intensive care units, improving device alerts, workflow efficiency, and creating a quieter environment for patients.
- Surgical Instrument Management: The company’s sterile goods management system helps optimize resource processes, ensuring that healthcare professionals have the right tools at the right time, while significantly reducing waste.
- Dialysis Portfolio: B. Braun introduced a virtual reality training program for medical staff working with dialysis machines, enhancing learning flexibility and reducing operational disruptions.
These innovations not only improve healthcare efficiency but also directly contribute to better patient outcomes and reduced operational costs for healthcare providers.
Growing Workforce and Global Reach
B. Braun’s commitment to innovation is supported by its growing workforce, which increased to 64,262 employees in 2024. The company’s strategic hires in production and research and development reflect its ongoing investment in talent and diversity. B. Braun’s global reach was also evident in 2024, with its products and solutions being used in 194 countries.
Anna Maria Braun expressed her appreciation for the company’s employees, stating, “The diversity of our workforce is essential for us to successfully develop and market our portfolio worldwide. I would like to thank every employee for their commitment, ability to change, and flexibility in the past fiscal year.”
Looking Ahead
B. Braun’s 2024 results reinforce its position as a leader in the healthcare sector, with a strong commitment to innovation, efficiency, and sustainability. The company’s continued focus on technological advancements and strategic investments sets the stage for further growth in the coming years, solidifying its role as a key partner in the global healthcare landscape.